CD4 and tuberculosis: Since LTBI simulations start with fewer CD4+ T cells and end with far more CD4+ T cells than naïve simulations, these parameter differences might be more reflective of different phenotypes of TB-specific CD4+ T cells which is not explicitly accounted for in the current ABM.